-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2022.
- Eagle Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was $5.16M.
- Eagle Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was $11.9M, a 47.6% decline year-over-year.
- Eagle Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $35.6M.
- Eagle Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$8.63M, a 172% decline from 2020.
- Eagle Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was $12M, a 16.2% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)